ProTek Medical will continue to operate as a subsidiary of Molex Ireland. The company has a diverse portfolio, with success in applications that include cardiac rhythm management components, infusion finished devices and vascular delivery devices. A recipient of numerous customer awards, ProTek Medical has earned an industry reputation for design, engineering, manufacturing, finished assembly and testing of critical medical devices.
ProTek works closely with customers to ensure a seamless transition from prototype to production. Its experienced team has built valued partnerships with a number of top tier medical device, biotech and pharmaceutical manufacturers in Europe and North America. This acquisition also expands the Molex medical footprint to Ireland, which has a large concentration of successful medical device companies.